OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-1.86%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$332M
AUM Growth
+$332M
(-36%)
Cap. Flow
-$51.3M
Cap. Flow
% of AUM
-15.43%
Top 10 Holdings %
Top 10 Hldgs %
97.76%
Holding
18
New
1
Increased
5
Reduced
4
Closed
3
Top Buys
| 1 |
AGEN
Agenus
AGEN
|
$6.34M |
| 2 |
QuidelOrtho
QDEL
|
$4.79M |
| 3 |
ATRS
Antares Pharma, Inc.
ATRS
|
$1.27M |
| 4 |
Y-mAbs Therapeutics
YMAB
|
$658K |
| 5 |
Pacific Biosciences
PACB
|
$336K |
Top Sells
| 1 |
DERM
Dermira, Inc.
DERM
|
$38.3M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$13.6M |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$7.91M |
| 4 |
Cencora
COR
|
$2.13M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$1.79M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
QuidelOrtho
QDEL
$1.95B
| $177M | 52.48% | 1,805,983 +48,995 | +3% | +$4.79M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $63.7M | 18.91% | 1,870,743 -52,547 | -3% | -$1.79M |
|
|
AXDX
3
DELISTED
Accelerate Diagnostics
AXDX
| $34.2M | 10.15% | 4,102,287 -110,865 | -3% | -$924K |
|
|
AGEN
4
Agenus
AGEN
$133M
| $13.1M | 3.9% | 5,360,867 +2,588,764 | +93% | +$6.34M |
|
5
Soleno Therapeutics
SLNO
$3.6B
| $9.21M | 2.74% | 3,870,627 | – | – |
|
|
VRML
6
DELISTED
Vermillion, Inc.
VRML
| $8.18M | 2.43% | 9,825,289 | – | – |
|
|
AMRN
7
Amarin Corp
AMRN
$311M
| $7.34M | 2.18% | 1,835,639 -3,390,366 | -65% | -$13.6M |
|
8
Opko Health
OPK
$1.1B
| $5.99M | 1.78% | 4,473,076 +100,000 | +2% | +$134K |
|
|
9
Pacific Biosciences
PACB
$393M
| $3.73M | 1.11% | 1,220,359 +109,693 | +10% | +$336K |
|
|
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
| $2.9M | 0.86% | 1,227,114 +538,877 | +78% | +$1.27M |
|
|
MOTS
11
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $2.57M | 0.76% | 3,806,666 | – | – |
|
|
BIOL
12
DELISTED
Biolase, Inc.
BIOL
| $1.94M | 0.58% | 5,173,250 | – | – |
|
13
Biogen
BIIB
$19.4B
| $1.54M | 0.46% | 4,868 | – | – |
|
|
CFRX
14
DELISTED
ContraFect Corporation
CFRX
| $742K | 0.22% | 128,845 -1,373,921 | -91% | -$7.91M |
|
|
15
Y-mAbs Therapeutics
YMAB
$388M
| $658K | 0.2% | +25,212 | New | +$658K |
|
|
16
Cencora
COR
$56.5B
| – | – | -25,000 | Closed | -$2.13M |
|
17
Deutsche Bank
DB
$67.7B
| – | – | -25,000 | Closed | -$195K |
|
|
DERM
18
DELISTED
Dermira, Inc.
DERM
| – | – | -2,528,311 | Closed | -$38.3M |
|